| Synonyms: | |
| Status: | Approved (2020) |
| Entry Type: | Small molecule |
| Molecule Category: | Salt |
| UNII: | 807ME4B7IJ |
| Parent Compound: | SELUMETINIB |
| InChI Key | GRKFGZYYYYISDX-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C17H17BrClFN4O7S |
| Molecular Weight | 555.77 |
| AlogP | 3.53 |
| Hydrogen Bond Acceptor | 6.0 |
| Hydrogen Bond Donor | 3.0 |
| Number of Rotational Bond | 6.0 |
| Polar Surface Area | 88.41 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 3.0 |
| Heavy Atoms | 27.0 |
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | Dual specificity mitogen-activated protein kinase kinase; MEK1/2 inhibitor | FDA |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Neurofibromatosis 1 | 4 | D009456 | FDA |
| Astrocytoma | 3 | D001254 | ClinicalTrials |
| Pancreatic Neoplasms | 2 | D010190 | ClinicalTrials |
| Melanoma | 1 | D008545 | ClinicalTrials |
| Melanoma | 1 | D008545 | ClinicalTrials |
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL2105684 |
| EPA CompTox | DTXSID40241430 |
| FDA SRS | 807ME4B7IJ |
| PubChem | 16214875 |
| SureChEMBL | SCHEMBL2354340 |